Breast Cancer News The updated guideline reviews advanced radiation therapy techniques and places emphasis on multidisciplinary care.
Researchers found a significant increase in the risk of breast cancer among men who had not fathered any children.
The findings contradict results from the phase 3 BEACON study.
The risk of dying from a subsequent primary cancer remained significantly elevated for 20 years or more for some patients.
A DBT-based risk model can predict cancer after a negative screening exam, with high discriminative performance for one-year risk.
There were no significant differences in outcomes between patients with low HER2 expression and those with no HER2 expression, after adjusting for hormone receptor status.
Combining ceralasertib with olaparib did not improve response rates or progression-free survival.
Adding ribociclib to fulvestrant prolonged overall survival by 15.8 months.
Patritumab deruxtecan produced “clinically meaningful” responses, according to researchers.
Nearly half of the systematic reviews supporting 5 guidelines were of “critically low” quality.
Of more than 100 studies used to support drug approvals, none reported information on the gender of participants.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Quality of life outcomes were reported favorably for trials that showed no improvement in quality of life.
The approval was based on data from the phase 3 DESTINY-Breast03 trial.
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
Researchers found that, in 18% of recurrences, the new tumor was molecularly unrelated to the original tumor.
Multiple sclerosis was associated with reduced odds of screen-detected breast cancer.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
Axillary lymphadenopathy persisted up to 43 weeks after COVID-19 vaccination.
Researchers investigated the association between NAFLD and the risk of extrahepatic cancers.
Load More